0HTC.L

Cara Therapeutics, Inc. [0HTC.L] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

0HTC.L Stock Summary

Top 10 Correlated ETFs

0HTC.L


Top 10 Correlated Stocks

0HTC.L


In the News

0HTC.L Financial details

Company Rating
Neutral
Market Cap
49.49M
Income
-118.51M
Revenue
20.97M
Book val./share
1.05
Cash/share
1.86
Dividend
-
Dividend %
-
Employees
55
Optionable
No
Shortable
Yes
Earnings
13 May 2024
P/E
-0.32
Forward P/E
-0.75
PEG
-0.09
P/S
1.77
P/B
0.43
P/C
0.44
P/FCF
-0.38
Quick Ratio
3.58
Current Ratio
4.4
Debt / Equity
0.65
LT Debt / Equity
0.65
-
-
EPS (TTM)
-2.18
EPS next Y
-1.1
EPS next Q
-0.41
EPS this Y
37.74%
EPS next Y
-49.63%
EPS next 5Y
-86.93%
EPS last 5Y
-2.53%
Revenue last 5Y
1.07%
Revenue Q/Q
-38.27%
EPS Q/Q
13.46%
-
-
-
-
SMA20
11.54%
SMA50
42.62%
SMA100
-28.69%
Inst Own
-
Inst Trans
-
ROA
-101%
ROE
-95%
ROC
-1.3%
Gross Margin
-431%
Oper. Margin
-566%
Profit Margin
-549%
Payout
-
Shs Outstand
56.73M
Shs Float
48.18M
-
-
-
-
Target Price
-
52W Range
0.5-5.815
52W High
-
52W Low
-
RSI
49
Rel Volume
0.64
Avg Volume
18.63K
Volume
11.97K
Perf Week
-2.95%
Perf Month
47.32%
Perf Quarter
-43.1%
Perf Half Y
-52.59%
-
-
-
-
Beta
0.695
-
-
Volatility
0.05%, 0.13%
Prev Close
4.43%
Price
0.825
Change
-4.06%

0HTC.L Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2023-12-31

Metric History 2019-12-312020-12-312021-12-312022-12-31 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.472.850.450.780.39
Net income per share
-2.490.18-1.74-1.59-2.19
Operating cash flow per share
-2.56-0.12-1.18-1.47-1.7
Free cash flow per share
-2.56-0.12-1.19-1.47-1.74
Cash per share
3.633.823.292.721.87
Book value per share
4.385.254.492.961.05
Tangible book value per share
4.385.254.492.961.05
Share holders equity per share
4.385.254.492.961.05
Interest debt per share
0.020.030.030.040.7
Market cap
1.02B955M640.58M579.89M39.53M
Enterprise value
1.01B928.59M630.8M517.66M30.51M
P/E ratio
-9.6113.56-7.24-6.78-0.33
Price to sales ratio
51.377.0727.8213.851.89
POCF ratio
-9.35-174.05-10.66-7.37-0.43
PFCF ratio
-9.35-163.64-10.65-7.36-0.42
P/B Ratio
5.473.842.823.650.69
PTB ratio
5.473.842.823.650.69
EV to sales
50.666.8727.3912.361.46
Enterprise value over EBITDA
-9.09145.09-7.21-6.03-0.25
EV to operating cash flow
-9.22-169.23-10.5-6.58-0.33
EV to free cash flow
-9.22-159.11-10.49-6.57-0.32
Earnings yield
-0.10.01-0.14-0.15-3
Free cash flow yield
-0.11-0.01-0.09-0.14-2.39
Debt to equity
0.010.010.010.010.65
Debt to assets
00.010.010.010.29
Net debt to EBITDA
0.13-4.130.110.720.07
Current ratio
3.8610.559.847.24.54
Interest coverage
0000-201.15
Income quality
1.03-0.650.680.920.78
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.880.161.260.710
Research and developement to revenue
5.720.83.592.195.17
Intangibles to total assets
00000
Capex to operating cash flow
00.06000.03
Capex to revenue
0000-0.11
Capex to depreciation
-0.02-0.34-0.03-0.03-9.17
Stock based compensation to revenue
0.630.110.90.420
Graham number
15.674.5813.2710.37.21
ROIC
-0.580.02-0.39-0.54-1.21
Return on tangible assets
-0.460.03-0.36-0.47-0.94
Graham Net
2.583.382.952.360.68
Working capital
122.76M176.58M155.67M145.45M90.57M
Tangible asset value
186.71M249M227.52M158.78M57.09M
Net current asset value
119.41M172.91M153.76M145.45M47.4M
Invested capital
0.010.010.010.010.65
Average receivables
893.5K1.93M1.61M2.8M4.24M
Average payables
6.74M7M5.26M7.61M10.59M
Average inventory
001.29M2.48M2.6M
Days sales outstanding
32.85.5818.2638.8269.93
Days payables outstanding
29.3516.681.32K466.52657.2
Days of inventory on hand
00606.92115.76160.06
Receivables turnover
11.1365.4519.999.45.22
Payables turnover
12.4421.880.280.780.56
Inventory turnover
000.63.152.28
ROE
-0.570.03-0.39-0.54-2.08
Capex per share
0-0.0100-0.04

Quarterly Fundamentals Overview

Last date of statement is 2023-12-31 for Q4

Metric History 2022-12-312023-03-312023-06-302023-09-30 2023-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
0.060.110.130.090.06
Net income per share
-0.56-0.49-0.58-0.52-0.59
Operating cash flow per share
-0.44-0.64-0.38-0.36-0.32
Free cash flow per share
-0.44-0.64-0.38-0.37-0.36
Cash per share
2.712.131.761.461.86
Book value per share
2.952.542.021.581.05
Tangible book value per share
2.952.542.021.581.05
Share holders equity per share
2.952.542.021.581.05
Interest debt per share
0.040.030.020.010.69
Market cap
581.07M268.76M154.45M88.95M39.77M
Enterprise value
518.84M222.42M96.77M32.98M30.75M
P/E ratio
-4.79-2.52-1.23-0.79-0.31
Price to sales ratio
178.1943.5922.2818.2813.24
POCF ratio
-24.72-7.76-7.55-4.53-2.29
PFCF ratio
-24.72-7.76-7.55-4.45-2.05
P/B Ratio
3.661.971.421.040.7
PTB ratio
3.661.971.421.040.7
EV to sales
159.136.0813.966.7810.24
Enterprise value over EBITDA
-16.8-8.17-3.03-1.16-0.95
EV to operating cash flow
-22.07-6.42-4.73-1.68-1.77
EV to free cash flow
-22.07-6.42-4.73-1.65-1.58
Earnings yield
-0.05-0.1-0.2-0.32-0.81
Free cash flow yield
-0.04-0.13-0.13-0.22-0.49
Debt to equity
0.010.010.010.010.65
Debt to assets
0.010.010.0100.29
Net debt to EBITDA
2.021.71.811.970.28
Current ratio
7.28.554.94.44.54
Interest coverage
0000-53.99
Income quality
0.771.30.650.70.54
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
1.931.11.071.360
Research and developement to revenue
7.973.944.375.229.44
Intangibles to total assets
00000
Capex to operating cash flow
0000.020.12
Capex to revenue
000-0.07-0.68
Capex to depreciation
000-0.62-25.02
Stock based compensation to revenue
0.890.540.50.690
Graham number
6.125.315.144.293.74
ROIC
-0.19-0.2-0.29-0.31-0.33
Return on tangible assets
-0.17-0.17-0.23-0.24-0.26
Graham Net
2.361.951.481.020.68
Working capital
145.45M125.98M99.28M77.72M90.57M
Tangible asset value
158.78M136.6M108.93M85.64M57.09M
Net current asset value
145.45M125.98M99.28M70.91M47.4M
Invested capital
0.010.010.010.010.65
Average receivables
7.61M5.86M9.25M8.49M4.87M
Average payables
12.41M7.01M8.27M10.05M9.78M
Average inventory
2.11M2.95M3.47M3.34M3.04M
Days sales outstanding
122.9105.96145.92105.98120.35
Days payables outstanding
394.5150.36738.15444.041.51K
Days of inventory on hand
97.89119.47208.25181.78367.96
Receivables turnover
0.730.850.620.850.75
Payables turnover
0.230.60.120.20.06
Inventory turnover
0.920.750.430.50.24
ROE
-0.19-0.2-0.29-0.33-0.57
Capex per share
000-0.01-0.04

0HTC.L Frequently Asked Questions

What is Cara Therapeutics, Inc. stock symbol ?

Cara Therapeutics, Inc. is a US stock , located in Stamford of Ct and trading under the symbol 0HTC.L

What is Cara Therapeutics, Inc. stock quote today ?

Cara Therapeutics, Inc. stock price is $0.825 today.

Is Cara Therapeutics, Inc. stock public?

Yes, Cara Therapeutics, Inc. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap